AFT Pharma strikes licensing deal with Swiss company to sell Maxigesic in 69 countries

Fiona Rotherham
Sun, 28 Feb 2016

By Fiona Rotherham Feb. 29 (BusinessDesk) -  AFT Pharmaceuticals has reached agreement with privately-owned Swiss headquartered multinational pharmaceutical company Acino Pharma AG to out-license the Auckland drug-maker’s main product, the patented combination painkiller Maxigesic to a further 69 countries. The shares rose.  The agreement is to sell all oral dose forms of Maxigesic and Maxigesic 1V in four geographic regions – Saudi Arabia and Yemen, Central America and the Caribbean, Africa, and North Africa and Levant. AFT markets more...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

The Quiz FREE
QuiznessDesk, Monday, May 23, 2022
The Quizmaster | Mon, 23 May 2022

This chilly weather is the perfect time for you to test your smarts in our daily quiz. Good luck!

Power play: Spark moves on Genesis trademark
Victoria Young | Mon, 23 May 2022

Spark moves to block Genesis from expanding its challenger brand.

Profile FREE
Designer's life is not a dress rehearsal
Ella Somers | Mon, 23 May 2022

"At the end of the day, it makes me really happy to design garments that women treasure and feel empowered in," womenswear designer Natalie Procter says.

Partner content
What’s driving the ram raids, and what shop owners can do

Scott La Franchie explains the motivations behind the spate of burglaries.

Partner content
Grow your business by taking time to plan

Getting business fundamentals right gives the best chance at beating the unplannable.